KPV Signals Through Non-Classical Pathways in Skin Cells: cAMP-Independent Anti-Inflammatory Action
KPV (alpha-MSH 11-13) inhibited NF-κB inflammatory signaling in human keratinocytes through a cAMP-independent pathway, distinct from full-length alpha-MSH which uses the classical cAMP-MC1R route.
Quick Facts
What This Study Found
KPV inhibited NF-κB inflammatory signaling in human keratinocytes through a cAMP-independent mechanism, distinct from full-length alpha-MSH's classical cAMP-dependent MC1R signaling.
Key Numbers
How They Did This
In-vitro study using human keratinocyte HaCaT cells. Alpha-MSH, KPV, and ACTH effects on cAMP levels and NF-κB activation compared. Melanocortin receptor expression characterized.
Why This Research Matters
KPV's non-classical mechanism means it works differently from the parent peptide. Understanding this alternative pathway could enable optimization of KPV-based anti-inflammatory therapies for skin.
The Bigger Picture
KPV's non-classical signaling challenges the assumption that melanocortin anti-inflammation requires cAMP. This opens new mechanistic understanding and drug design possibilities.
What This Study Doesn't Tell Us
Single keratinocyte cell line (HaCaT). The specific non-cAMP mechanism (direct intracellular entry? alternative receptor?) was not identified.
Questions This Raises
- ?Does KPV enter cells directly to inhibit NF-κB?
- ?What is the non-cAMP mechanism for KPV's anti-inflammatory effect?
- ?Does this non-classical mechanism work in other cell types (gut, immune)?
Trust & Context
- Key Stat:
- Different pathway KPV blocks inflammation WITHOUT using alpha-MSH's classical cAMP pathway — it accesses NF-κB inhibition through an entirely different, non-classical mechanism
- Evidence Grade:
- Preliminary in-vitro evidence demonstrating pathway dissociation between KPV and full-length alpha-MSH signaling in skin cells.
- Study Age:
- Published in 2004. KPV's non-classical signaling has been further studied, with evidence supporting direct intracellular mechanisms.
- Original Title:
- alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells.
- Published In:
- The Journal of investigative dermatology, 122(4), 1010-9 (2004)
- Authors:
- Elliott, Richard J, Szabo, Marika, Wagner, Mark J, Kemp, E Helen, MacNeil, Sheila, Haycock, John W
- Database ID:
- RPEP-00907
Evidence Hierarchy
Frequently Asked Questions
How does KPV reduce skin inflammation?
Not through the normal melanocortin receptor pathway. KPV bypasses the classical cAMP signaling and goes directly to blocking NF-κB — the master inflammatory switch — through an alternative mechanism.
Does this make KPV better for skin?
It makes it different. Since KPV uses a non-classical pathway, it might work even in situations where the classical melanocortin receptor pathway is dysfunctional — potentially beneficial for certain skin conditions.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00907APA
Elliott, Richard J; Szabo, Marika; Wagner, Mark J; Kemp, E Helen; MacNeil, Sheila; Haycock, John W. (2004). alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells.. The Journal of investigative dermatology, 122(4), 1010-9.
MLA
Elliott, Richard J, et al. "alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells.." The Journal of investigative dermatology, 2004.
RethinkPeptides
RethinkPeptides Research Database. "alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adre..." RPEP-00907. Retrieved from https://rethinkpeptides.com/research/elliott-2004-alphamelanocytestimulating-hormone-msh-1113
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.